98%
921
2 minutes
20
Background: Colorectal cancer (CRC) is a major global public health concern, yet screening participation remains low among at-risk populations. This study investigated factors influencing attendance at CRC screening services among at-risk individuals aged 50-70 years.
Methods: A cross-sectional analytical study was conducted from November 2023 to February 2024, involving 360 participants aged 50-70 years. The sample included 180 cases (participants who attended CRC screening) and 180 controls (those who did not), selected through simple random sampling from a registry of at-risk individuals. Data were collected using validated questionnaires assessing demographic characteristics, health literacy, social, and family support. The content validity indices ranging from 0.66 to 1.00 with Cronbach's alpha coefficients of 0.91, 0.88, and 0.77, respectively. Descriptive statistics and multiple logistic regression were used for analysis.
Results: Annual physical check-ups and body mass index (BMI) were significantly associated with screening attendance with CRC screening attendance. Individuals without annual check-ups were 55% less likely to attend CRC screening (Adjusted Odds Ratio [AOR] = 0.45, 95% Confidence Interval [CI]: 0.29-0.70). Those with a normal BMI were 3.91 times more likely to attend screening compared to those with underweight BMI (AOR = 3.91, 95% CI: 1.20-12.77), after adjusting for gastrointestinal disease history.
Conclusions: Regular health check-ups and BMI play crucial roles in CRC screening participation. Targeted health interventions are essential to improve awareness and encourage screening participation, particularly among individuals lacking routine check-ups. Strengthening preventive healthcare efforts can help reduce CRC prevalence and enhance public health outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374496 | PMC |
http://dx.doi.org/10.31557/APJCP.2025.26.6.2163 | DOI Listing |
Public Health
September 2025
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Objectives: Participation rates in fecal immunochemical test (FIT)-based colorectal cancer (CRC) screening differ across socio-demographic subgroups. The largest health gains could be achieved in subgroups with low participation rates and high risk of CRC. We investigated the CRC risk within different socio-demographic subgroups with low participation in the Dutch CRC screening program.
View Article and Find Full Text PDFCancer Pathog Ther
September 2025
Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, India.
Background: Colorectal cancer (CRC) is a complex, heterogeneous disease characterized by frequent relapses and metastasis. Previous studies have reported that the invasion and progression of CRC in several cases can be controlled by targeting fusion genes. This study aimed to screen for potent fusion transcripts as potential molecular biomarkers and therapeutic targets for metastatic CRC (mCRC) using an approach.
View Article and Find Full Text PDFBioimpacts
August 2025
Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara 06330, Türkiye.
Colorectal cancer (CRC) constitutes a significant global health challenge, accounting for a considerable proportion of cancer cases and associated mortality. Projections indicate a potential increase in new cases by 2040, attributed to demographic factors such as aging and population growth. Although advancements in the understanding of CRC pathophysiology have broadened treatment options, challenges such as drug resistance and adverse effects persist, highlighting the necessity for enhanced diagnostic methodologies.
View Article and Find Full Text PDFCancer Rep (Hoboken)
September 2025
Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Background And Objectives: Colorectal cancer (CRC) screening and early detection reduce mortality. Curative treatment is based on surgical resection, and pathological analysis plays a key role in management. In Lebanon, the impact of the COVID-19 pandemic on healthcare has been compounded by an unprecedented socio-economic crisis in 2020.
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of General Surgery, Beijing Tongren Hospital, Beijing, China.
This study investigates the clinical value of plasma Septin-9 gene methylation (mSEPT9) and carcinoembryonic antigen (CEA) in colorectal cancer (CRC), and their correlations with clinicopathological features and recurrence. A retrospective study included 81 CRC patients (observation group) and 73 healthy controls (comparison group) from January 2021 to January 2023, with pathological diagnosis as the gold standard. Plasma mSEPT9 (via quantitative PCR) and CEA (via electrochemiluminescence) levels were measured.
View Article and Find Full Text PDF